Sinopharm group Weiqida Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Shanghai Modern Pharmaceutical Co., Ltd., is located in the pharmaceutical industrial park of Datong Economic and Technological Development Zone, Shanxi Province. Its holding company, Sinopharm group Datong Weiqida Zhongkang Pharmaceutical Co., Ltd., covers a total area of 1314 Mu and has 4310 employees.

The company has two production plants. Sinopharm Wichita, located in the first pharmaceutical Park, mainly produces cephalosporin pharmaceutical intermediates, APIs, powder injections and clavulanate pharmaceutical APIs. It is a world-renowned supplier of clavulanate potassium; Located in the second pharmaceutical Park, Wichita Zhongkang pharmaceutical mainly produces penicillin pharmaceutical intermediates, APIs, oral solid preparations and powder injections.

Sinopharm Wichita and Wichita Zhongkang pharmaceutical have the production capacity of three parent nuclei of 7aca, 6apa and d-7aca antibiotics, and form a complete industrial chain of cephalosporins and penicillins from basic raw materials to terminal preparations. Their products are highly competitive in domestic and foreign markets.